Literature DB >> 12163813

Skin necrosis after extravasation of low-dose vasopressin administered for septic shock.

Jeremy M Kahn1, John P Kress, Jesse B Hall.   

Abstract

OBJECTIVE: To describe a case of severe skin necrosis resulting from peripheral intravenous administration of low-dose vasopressin in a patient with catecholamine-resistant septic shock.
DESIGN: Case report.
SETTING: Medical intensive care unit at the University of Chicago, Chicago, IL. PATIENT: A 46-yr-old female with ventilator-dependent, proliferative-phase acute respiratory distress syndrome complicated by Pseudomonas aeruginosa bacteremia and sepsis.
MEASUREMENTS AND MAIN RESULTS: A patient recovering from acute respiratory distress syndrome developed septic shock from Pseudomonas aeruginosa bacteremia while in the medical intensive care unit. Vasopressin (0.04 units/min) was administered through a peripheral venous catheter for hypotension unresponsive to exogenous catecholamines. The patient subsequently developed severe ischemic necrosis of the skin and soft tissue surrounding the catheter site. The vasopressin was stopped, and the skin lesion progressed to bullae formation with extensive superficial erosion.
CONCLUSIONS: Peripheral administration of low-dose vasopressin for septic shock should be discouraged because of the risk of ischemic skin complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163813     DOI: 10.1097/00003246-200208000-00038

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  Ischemic through-and-through necrosis of the lateral wall of the torso and inguinal region subsequent to flame injury and septic shock: a case report and literature review.

Authors:  I Tocco-Tussardi; B Presman; Z Sleem; F Huss
Journal:  Ann Burns Fire Disasters       Date:  2018-03-31

Review 2.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

3.  Admission plasma vasopressin levels in children with meningococcal septic shock.

Authors:  F Leclerc; E Walter-Nicolet; S Leteurtre; O Noizet; A Sadik; R Cremer; C Fourier
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

4.  Variation of arterial and central venous catheter use in United States intensive care units.

Authors:  Hayley B Gershengorn; Allan Garland; Andrew Kramer; Damon C Scales; Gordon Rubenfeld; Hannah Wunsch
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

5.  Effects of Low Dose Vasopressin in Catecholamine Resistant Septic Shock.

Authors:  R M Sharma; R Setlur; K Prabhakaran; A Rai
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Alternative Pharmacological Management of Vasopressor Extravasation in the Absence of Phentolamine.

Authors:  Michelle Plum; Oussayma Moukhachen
Journal:  P T       Date:  2017-09

7.  [Role of vasopressin in septic shock : critical evaluation].

Authors:  I Gradwohl-Matis; A Brunauer; D Dankl; M Dünser
Journal:  Anaesthesist       Date:  2014-06       Impact factor: 1.041

8.  Vasopressin: Its current role in anesthetic practice.

Authors:  Jayanta K Mitra; Jayeeta Roy; Saikat Sengupta
Journal:  Indian J Crit Care Med       Date:  2011-04

9.  Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock.

Authors:  Eun Hee Kim; Sae Hwan Lee; Seung Woon Byun; Ho Suk Kang; Dong Hoe Koo; Hyun-Gu Park; Sang Bum Hong
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

10.  Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Andrew M Harrison; Perliveh Carrera; Narat Srivali; Wonngarm Kittamongkolchai; Aysen Erdogan; Kianoush B Kashani
Journal:  BMC Pharmacol Toxicol       Date:  2016-05-07       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.